Strategic Initiative

Slingshot members are tracking this corporate initiative:

Transgene (TRGNF) enters into a research, option and license deal with AstraZeneca (AZN) in oncolytic virus immunotherapies

Source Link:
https://www.astrazeneca.com/media-centre/medical-releases/astrazeneca-enters-strategic-collaboration-with-transgene-to-develop-innovative-oncolytic-virus-immunotherapies30042019.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AZN
100%
TRGNF
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
May 02, 2019
Projected Implementation:
Q2, 2019
Relevance Tracked Until:
Q3, 2019
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Oncolytic Immunotherapy, Immune System, Cancer Immunotherapy
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.